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ABSTRACT  
Background: The traditional evaluation of gait in the laboratory during structured testing has provided 
important insights, but is limited by its “snapshot” character and observation in an unnatural 
environment. Wearables enable monitoring of gait in real-world environments over a week. Initial 
findings show that in-lab and real-world measures differ.  As a step towards better understanding 
these gaps, we directly compared in-lab usual-walking (UW) and dual-task walking (DTW) to daily-
living measures of gait. 
Methods: In-lab gait features (e.g., gait speed, step and stride regularity) derived from UW and DTW 
were compared to the same gait features during daily-living in 150 elderly fallers (age: 76.5±6.3 years, 
37.6% men). In both settings, features were extracted from a lower-back accelerometer. In the real-
world setting, subjects were asked to wear the device for one week and pre-processing detected 30-
second daily-living walking bouts. A histogram of all walking bouts was determined for each walking 
feature for each subject and then each subject's typical (percentile 50, median), worst (percentile 10) 
and the best (percentile 90) values over the week were determined for each feature. Statistics of 
reliability were assessed using Intra-Class correlations and Bland-Altman plots.  
Results: As expected, in-lab gait speed, step regularity, and stride regularity were worse during DTW, 
compared to UW.  In-lab gait speed, step regularity, and stride regularity during UW were significantly 
higher (i.e., better) from the typical daily-living values (p<0.001) and different (p<0.001) from the 
worst and best values. DTW values tended to be similar to typical daily-living values (p=0.205, p=0.053, 
p=0.013 respectively). ICC assessment and Bland-Altman plots indicated that in-lab values do not 
reliably reflect the daily-walking values. 
Conclusions: Gait values measured during relatively long (30-second) daily-living walking bouts are 
more similar to the corresponding values obtained in the lab during dual-task walking, as compared 
to usual walking. Still, gait performance during most daily-living walking bouts is worse than that 
measured during usual and dual-tasking in the lab. The values measured in the lab do not reliably 
reflect daily-living measures. That is, an older adult’s typical daily-living gait cannot be estimated by 
simply measuring walking in a structured, laboratory setting.  
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BACKGROUND 
Among older adults, gait is one of the keys to functional independence and gait changes are associated 
with and predictive of numerous adverse health outcomes. These include falls, mobility impaired, 
cognitive decline, dementia, and even mortality [1-3]. Until recently, gait assessments were generally 
conducted in specialized laboratory facilities, under well-defined, scripted conditions. These tests 
provided important insight into gait impairments in aging and pathology [4-14]. Cognitive "dual 
tasking" paradigms were added to enhance short, in-lab testing in an attempt to make them more 
reflective of the many motor-cognitive challenges that occur during every-day ambulation [15-26]. 
Dual-tasking studies demonstrated that in older adults, people with neurodegenerative diseases, and 
many other cohorts with impaired walking abilities, gait speed is reduced, gait variability becomes 
larger, and asymmetry often increases. At the same time, there is increased reliance on cortical 
function, in particular, the pre-frontal cortex, during walking [27-31]. Dual-task walking abilities and 
this increased pre-frontal cortex activation have also been related to fall risk [17,32]. This suggests 
that during every-day walking, when many secondary tasks provide challenging situations, dual-task 
walking is commonplace and critical to functional independence. Interestingly, although dual-task 
walking is presumed to be ubiquitous, an estimate describing how common it is does not yet exist. 
Thus, its impact on daily-living walking can only be inferred.  
 
Body-worn sensors, also referred to as wearables, now provide an inexpensive opportunity for the 
continuous monitoring of ambulatory activity in free-living environments [7,9,33-39]. The basic 
elements of gait are similar regardless of where a subject is tested. Yet, like the ambulatory monitoring 
of real-world arrhythmias and seizures, multi-day, continuous recordings of gait putatively provide 
metrics that capture the complexities and multiple influences on real-world gait [40] that are not fully 
reflected when subjects are assessed in the laboratory or clinic. These every-day influences likely 
include dual and multi-tasking, planning, obstacle negotiation, fatigue, motivation, mind wandering, 
and mood. Previous studies using wearables to assess daily-living gait have shown the value of such 
measurements, for example, in predicting future falls among older adults [7,33-39,41]. At the same 
time, a growing body of literature suggests that the values of the gait measures extracted from daily-
living differ from those extracted during testing in the laboratory [7,10,11,33,39,42-46]. The reasons 
for this gap are, however, not yet fully clear. 
 
Previous studies have generally compared in-lab usual walking to daily-living measures, however, a 
direct comparison of in-lab dual tasking gait to daily-living gait has not yet been conducted. We 
speculate that perhaps the dual- and multi-tasking that occurs during daily-living may contribute to 
the gap between in-lab usual walking and daily-living walking.  As a step toward better understanding 
the gap between in-lab gait and daily-living gait, here we sought to examine the role of dual-tasking.  
In particular, in the present study, we directly compare in-lab to daily-living gait in older adults with a 
history of falls in order to elucidate the relationship between the measures obtained in each setting 
and to gain insight into daily-living walking. We focused on five spatial-temporal gait features that are 
commonly used to evaluate and characterize in-lab usual walking and in-lab dual-task walking and 
sought to address the following questions: Is daily-living gait comparable to usual walking, as 
measured in the laboratory? Stated alternatively, is daily-living gait, which typically takes place in a 
complex, cognitively challenging environment, more similar to dual-task walking as measured in the 
laboratory?  About how much of daily-living walking is worse than in-lab dual-task walking?  
 
METHODS 
Participants 
The present analysis is based on the baseline assessment of subjects who participated in V-TIME, a 
multi-center (5 clinical sites), randomized controlled trial designed to reduce fall rates in older adults 
[47]. Briefly, individuals were enrolled if they were aged 60–90 years, on stable medications for the 
past month, able to walk for at least 5 minutes unassisted, and had at least 2 falls in the previous 6 
months. Individuals were excluded if they had psychiatric comorbidity (e.g., major depressive disorder 
as in accordance with DSM IV criteria); history of stroke, traumatic brain injury, or other neurological 
disorders (not including mild cognitive impairment); acute lower back or lower extremity pain; 
peripheral neuropathy; rheumatic and orthopedic diseases; or a clinical diagnosis of dementia or 
severe cognitive impairment (Mini Mental State Exam score <21). Subjects were characterized by age, 
gender, body-mass-index, and years of education. In addition, the Montreal Cognitive Assessment 
(MOCA) evaluated general cognitive function [48] (best possible score 30), the SF-36 assessed general 
health and physical function [49], and the Falls Efficacy Scale-International (FES-I) evaluated fear of 
falling (best and worst possible scores 16 and 64, respectively) [50]. The Short Physical Performance 
Battery (SPPB) (best possible score 12) [51], Mini-Balance Evaluation Systems Test (MINI-BEST) (best 
possible score 32) [52], and the Four Square Step Test (FSST) [53] assessed multiple aspects of balance, 
gait, and mobility in the lab.  
 
In-lab assessment of gait 
Participants walked back and forth in a well-lit, 15-meter long corridor for 1 minute under two walking 
conditions: (1) preferred, usual walking speed and (2) dual-task walking, i.e., while serially subtracting 
3 from a predefined 3-digit number while walking, with no task prioritization. The testing order was 
fixed.  To quantify gait, a lightweight body-fixed sensor (Opal APDM, Portland, Oregon) was attached 
with a belt to the lower back (lumbar vertebrae 4-5). The sensor includes a tri-axial accelerometer, 
gyroscope, and magnetometer (unit weight 22 g; unit size 48.5 mm × 36.5 mm × 13.5 mm; 128 Hz 
sampling rate).  
 
Daily-living assessment of gait 
At the end of the laboratory testing session, participants were asked to wear a tri-axial accelerometer 
(Axivity AX3, York, UK; dimensions: 23.0 × 32.5 × 7.6 mm; weight: 11 grams; 100 Hz sampling rate) for 
one week. The device was held in place with skin tape to the lower back (lumbar vertebrae 4-5). The 
participants were instructed to leave the device on throughout the week and to continue their daily 
activities as usual and not to change their routine. Upon completion of the recording, participants 
removed the device and mailed it back to one of the study sites for data processing. 
 
Data processing and analysis of gait 
The data analysis of the daily-living recordings included two stages: 1) Detection of all 30-second 
walking bouts [58]; and 2) Determination of the gait features in each bout, using the same algorithms 
as those used for in-lab testing. We focused on 30-second walking bouts, as this relatively long length 
most likely reflects purposeful, steady-state walking assessed in the lab and because relatively long 
walking episodes are more relevant for assessing walking quality [11,34,38,39,54]. The outcome 
measures for both in-lab and daily-living included step time, step length, gait speed, fundamental 
spatial-temporal gait measures, and were determined as previously described [55-58]. We also 
assessed step regularity, a measure of gait asymmetry (lower values reflect greater asymmetry) and 
stride regularity, a measure of the consistency of the walking pattern (higher values reflect greater 
stride-to-stride consistency and lower values reflect greater stride-to-stride variability) [59]. For each 
subject and for each feature, a histogram based on the value in all 30-second walking bouts was 
determined and then from this, each subject's typical (percentile 50, median), worst (percentile 10) 
and the best (percentile 90) values over the week were determined (see Figure 1 for an example). It 
should be noted that the terms “worst” and “best” are based on labels and interpretations that are 
usually applied to gait testing in the lab, however, it is not yet fully clear how to apply these terms to 
measures taken in daily life. In parallel, the outcome measures were extracted for laboratory walking 
bouts after removing turns and the first and last 3 steps of every walking bout to minimize start (i.e., 
acceleration and end (i.e., deceleration) effects [60]. Finally, we compared the features extracted from 
daily-living walking bouts to the in-lab usual and dual-task walking. 
 
Statistical Analyses 
Statistical analyses were carried out using SPSS v25 (SPSS Inc, Chicago, IL). To obtain an accurate 
assessment of daily-living walking, only subjects who had more than 3 days of data were included in 
the analyses [11]; thus 150 out of a possible 164 subjects were analyzed. Descriptive statistics (means 
and SD) were calculated for gait and subject characteristics. Outliers, defined as values more than 
three times the interquartile range, were identified and removed.  Paired t-tests were used to examine 
the relationship between each subject's typical, best, and worst daily-living walking bouts, on the one 
hand, and each subject's in-lab usual walking and dual-task walking, on the other hand. To minimize 
the effects of multiple comparisons, p values <0.001 were considered as significantly different. 
Statistics of reliability were assessed using Intraclass Correlation Coefficients (ICC2, 1) (two way mixed, 
absolute, single measures). ICCs values lower than 0.50 indicate poor reliability,  values between 0.50 
and 0.75 indicate moderate reliability, values between 0.75 and 0.90 indicate good reliability and 
values greater than 0.90 indicate excellent reliability [61]. 
 
RESULTS 
Subject characteristics are summarized in Table 1. The subjects had mild to moderate deficits in 
cognitive function, balance and physical performance. These characteristics are consistent with that 
expected of older adult fallers.  The light-blue bars in Figure 2 reflect the in-lab measures of usual-
walking and dual-task walking. In-lab gait speed during usual walking was 100.5±21.5 cm/s also 
consistent with that of older adults with mild to moderate impairment. As anticipated, during the in-
lab testing, a significant dual-task effect was seen.  For example, in-lab dual-tasking gait speed was 
lowered (p<0.0001) to 94.7±22.2 cm/s. During in-lab dual-tasking, step time did not change 
significantly (p=0.146), however, step length, step regularity, and stride regularity were significantly 
(p<0.0001) lower (i.e., worse) compared to in-lab usual-walking.   
 
Figure 2 summarizes the relationship between the gait values of daily-living worst, typical and best 
walking bouts and the in-lab measures of usual and dual-task walking. As seen in Figure 2a, in-lab step 
length during usual-walking was similar (p=0.516) to the typical daily-living value, higher than the 
daily-living worst, and lower than the best daily-living values (p<0.0001). In-lab dual-task step length 
differed from the best, worse, and typical daily-living values (p<0.0001). Gait speed during in-lab dual-
task walking was similar (p=0.205) to daily-living typical walking, while in-lab usual-walking gait speed 
was significantly different from the best (p<0.0001), worst (p<0.0001), and typical daily-living 
(p=0.004) values (Figure 2b). For step regularity and stride regularity, in-lab usual walking differed 
from the best, worse, and typical daily-living values (p<0.0001), while dual-task walking tended to be 
similar to typical daily-living values (p=0.053, p=0.013 respectively) (see Figure 2c and Figure 2d), 
parallel to what was seen for gait speed. For step time, in-lab usual walking step time and in-lab dual-
task walking values were similar to each other and similar (p>0.094) to the typical daily-living value 
(see Figure 2e).  
Table 2 summarizes the results of the agreement analyses comparing in-lab and daily-living walking 
bouts as evaluated using ICC and Pearson's correlation coefficients for all five gait features. There was 
good agreement between the values of step length during typical daily-living walking and in-lab usual-
walking and moderate agreement with in-lab dual-task walking. For gait speed, step regularity, stride 
regularity and step time, there was poor to moderate agreement between in-lab values (both usual 
and dual-task walking) with the typical values obtained during daily-living.  Example scatter plots and 
Bland-Altman plots are shown in Figure 3 for step length and gait speed, showing the relationship 
between individual values of in-lab dual tasking values and daily-living values. Many values of step 
length differed by more than ±5 cm and many values of gait speed differed by than 5 cm/sec (i.e., 
above the meaningful change difference [57]). This large range around the mean difference is 
consistent with the relatively high reproducibility coefficients (higher indicates worse reliability) and 
the high coefficient of variations (CVs) (higher indicates worse reliability) and suggests that the in-lab 
values do not reliably reflect the daily-walking values.   
 
To estimate what percent of each subject's daily-living walking was worse (e.g., lower) than the 
corresponding in-lab usual and dual-task walking values, the daily-living values were ranked and 
determined as a percentile (from 0-100, lowest to highest). This allowed us to estimate how the 
subject's in-lab values compare (rank) compared to his / her daily-living values. Figure 4 shows an 
example of gait speed and step regularity daily-living values ranked across all 30-second walking bouts 
along with the corresponding in-lab usual (green line) and dual-task (red line) values. In this example, 
in-lab usual walking and dual-tasking gait speed were 106.16 cm/sec and 91.71 cm/sec. This 
corresponds to the 94 percentile and 60 percentile, respectively, of the daily-living values of gait. In 
other words, in 94 % of all daily-living walking bouts, his gait speed was lower than in-lab usual walking 
gait speed and in 60 % of all daily-living walking bouts, his gait speed was lower than in-lab dual-tasking 
gait speed.    
 
Table 3 summarizes the percentage of the daily-living walking bouts whose values were worse than 
those in-lab usual and in-lab dual-task walking value. Averaged across all subjects, daily-living gait 
speed was lower than in-lab usual walking gait speed in 64% of the daily-living walking bouts and daily-
living gait speed was lower than in-lab dual-tasking gait speed in 51% of the walking bouts. To provide 
an overall summary and general impression, we averaged these percentages across all five gait 
features. 65% of the daily-living walks were lower than in-lab usual walk and about 55% of the daily-
living walks were lower than in-lab dual-task walk (fairly similar to the values for the individual 
features).  In other words, the in-lab measures of gait are better than a larger percent of daily-living 
walking.  
 
 
DISCUSSION 
In this cross-sectional study among 150 community-living older adults with mild to moderate deficits 
in cognitive function, balance and physical performance and multiple falls, we directly compared five 
commonly used spatial-temporal features of gait quality, as measured in the lab, to the corresponding 
values obtained during daily-living. When examining relatively long walking bouts (i.e., 30 seconds), 
we found three key findings:  1) the group mean values obtained in the lab during dual-task walking 
are generally similar to the values obtained during daily-living, at least on a group level; however, 2) 
the specific in-lab measures do not reliably reflect daily-living measures, as seen by the ICC analysis 
(with the exception of step length in usual walk which is in good agreement with typical daily-living 
value); 3) more than  50% of the walks in daily-living conditions are worse than the corresponding 
dual-task values as measured in the laboratory, which is worse than the values obtained during usual-
walking in the laboratory. 
 
In general, the comparison between daily-living and in-lab gait features revealed that most gait 
features obtained during daily-living were closer in value to the dual-task values measured in the 
laboratory setting (recall Figure 2). Consistent with this finding, the usual-walking measures obtained 
in the laboratory tended to be much better than the typical values obtained during daily-living (recall 
Figure 2), for most walking bouts (recall Table 3). At the same time, the intraclass correlation 
coefficients (Table 2) showed poor to good agreement in all the features, suggesting that the values 
obtained in the lab do not reliably reflect or agree with the same measures obtained during daily-
living. Indeed, in the Bland-Altman plot of gait speed (Figure 3b), many of the data points are above 
the meaningful change difference of 5 cm/sec [62], illustrating that differences between the in-lab 
and daily-living values are relatively large. Thus, while dual-tasking in-lab measures are apparently 
closer to the values determined from daily-living, one is still not a simple mirror image of the other.  
 
In the present study, we focused on the role of one factor that putatively contributes to the gap 
between in-lab usual-walking gait and daily-living gait, i.e., dual-tasking.  Cognitive-motor and motor-
motor dual and multi-tasking are common in daily life, e.g., walking while talking, while using a mobile 
phone, while carrying a bag, or while watching or negotiating traffic. It is now increasingly recognized 
that performing two or more tasks simultaneously negatively impacts the gait performance of older 
adults and that this change is related to adverse health outcomes in aging populations 
[17,21,23,32,63,64]. Thus, dual-tasking assessments have been added to augment short, in-lab testing 
in an attempt to make them better reflect the many motor-cognitive challenges that occur during 
every-day ambulation to reveal cognitive compensatory attempts [15-26,65] and to enhance the 
ecological relevance of the well-controlled, supervised in-lab testing. Interestingly, we found that gait 
performance in more than 55% of the daily-living, 30-second long walks are worse than performance 
observed during controlled testing in the laboratory, even compared with in-lab dual-task values 
(Table 3 and Figure 4). This finding implies that in-lab measures of gait, even dual-task walking 
features, do not provide an accurate reflection of daily-living gait measures. It also suggests that, as a 
rough approximation, much of daily-living walking apparently involves some factor(s) that makes the 
performance fall far below that seen during the testing of usual-walking. Given the ubiquitous nature 
of dual- and multi-tasking in daily-life, we can speculate that these everyday cognitive challenges 
contribute to the gap between in-lab and daily-living gait. This possibility is consistent with recent 
findings which showed that cognitive function is more closely correlated to real-world mobility than 
to laboratory-based  mobility [66]. Still, future studies that consider additional factors are needed to 
further tease out this question. In the meantime, though, it appears that in-lab usual-walking and dual-
task walking performance both overestimate much of every-day walking.  
 
Other factors likely also play an important role in the gap between daily-living and in-lab gait. For 
example, psychological factors like the Hawthorne effect [67] and reverse white coat syndrome [68] 
are likely to have a positive impact on testing in the lab, with minimal impact on daily-living gait. 
Factors like mood, depression, and fatigue may negatively impact daily-living gait, more so than on in-
lab gait, where study participants may attempt to put on their best effort, regardless of mood and 
fatigue. In addition to dual-tasking, these factors may have contributed to the gap that we observed 
(recall Figure 2). These ideas have led to the notion that testing in the laboratory represents what the 
subject can do, i.e., capacity, whereas testing during daily-living represents actual performance, 
function, and behavior, and not just intrinsic abilities [66,69,70]. From this perspective, it may be 
interesting to compare other types of walking in the laboratory, supervised setting (e.g., fast walking, 
obstacle negotiation, fatigued walking) to investigate how capacity in these conditions map to daily-
living gait.  
 
Several additional factors to consider are the environment and the nature of the walk. In daily-living, 
walking may not be along a straight-line. Curved walking has been studied in laboratory settings. It 
has been shown, for example, that multiple features of gait change during curved walking and when 
turning [71-76]. In general, during turns and curved walking, gait speed is reduced, asymmetry 
increases, and the gait pattern becomes more irregular, as compared to straight-line walking; all of 
these changes are consistent with the finding that typical daily-living gait values of gait speed, step 
regularity (i.e., symmetry), and stride regularity are all lower than the values seen when during testing 
in the laboratory (recall Figure 2). In addition, since some of the algorithms used for determining gait 
quality features assume straight-line, steady-state walking [59,77], applying them directly to daily-
living walks where subjects may walk in a curve, with sharp turns or abrupt changes in speed might 
influence the results. Other environmental elements (e.g., an inclined surface, cobblestone sidewalk, 
lighting) may also contribute to the differences between in-lab and daily-living walking.  In this context, 
it may be helpful to keep in mind that the terms “worst” and “best” were chosen according to gait 
performance in the lab. In daily life however, lower and higher values may not necessarily reflect worst 
and best and the interpretation of the values may depend on the environmental conditions, for 
example.  Perhaps the worst walking bouts during daily-living reflect walking in some of these 
environmental conditions and are actually an appropriate response (e.g., slower gait speed and 
shorter step length on a wet, slippery surface). Future work is needed to examine the impact of these 
additional factors on the gap between in-lab and daily-living gait. Future studies should also examine 
if and how the present findings apply to other groups (e.g., healthy older adults without a history of 
falls, older adults with widely studied neurological conditions such as Parkinson’s disease) and 
prospectively evaluate if the time spent in relatively poor walking during daily-living (recall Table 3) 
changes over time and responds to interventions. 
 
Bout length is also an important consideration. In the current analyses, we controlled for bout length 
by focusing on 30-second bouts in both the laboratory and daily-living settings. In everyday situations, 
most relatively long-walks, e.g., 30 seconds and longer, likely occur outside of the home (i.e., most 
homes do not have 30-meter long paths); in contrast, within the home or office setting, there are 
many short walking bouts [34]. If steady-state gait and walking performance are the questions of 
interest, relatively long bouts should be evaluated, as in the present study. At the same time, since 
much of daily-living gait takes place in very short bouts (<10 seconds) [33,34,78],  these bouts should 
also be considered when describing all of daily-living functioning.  
 
Conclusions 
In conclusion, the present findings suggest that in-lab measures of gait do not accurately reflect daily-
living gait measures. This is the case for in-lab usual-walking and also for in-lab dual-task walking. As 
noted in the introduction, the assessment of usual-walking and dual-task walking in laboratory settings 
is valuable, insightful, and clinically relevant, predicting important adverse health events. Nonetheless, 
the outcomes of our analyses indicate that this snapshot picture of gait does not accurately reflect 
every-day walking. Using an analogy from cardiology, the present results suggest that just as both the 
resting (in-lab) ECG and the continuous, daily-living Holter monitoring are informative for assessing 
and tracking cardiovascular risk, so too, the evaluation of gait based on both in-lab and daily-living 
testing apparently capture complementary aspects. Still, prospective and additional studies are 
needed to further demonstrate the utility of these daily-living measures of gait, to better understand 
what subject characteristics and other factor affect them and the gaps between in-lab and daily-living 
measures, and to more fully evaluate their potential in the assessment of fall risk, mobility 
impairment, cognitive decline, and related outcomes that affect many older adults. 
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FIGURE LEGENDS 
Figure 1: An example histogram from one subject of the values of gait speed obtained during 30-
second walking bouts across the week during the daily-living recording. The subject's typical (50%) gait 
speed was 98 cm/sec, the worst (10%) was 77 cm/sec and the best (90%) was 113 cm/sec. The use of 
descriptors "worst" and "best" is according to in-lab terminology where higher=better and 
lower=worst. These labels may not be appropriate when they are applied to some daily-living 
conditions (e.g., when walking on a wet, slippery surface, a slower gait speed and a shorter step length 
may actually be the most appropriate behavior and not the "worst" behavior).  
 
Figure 2: In-lab usual-walking and in-lab dual-task walking compared to daily-living walking typical, 
best and worst gait values of: a) step length; b) gait speed; c) step regularity; d) stride regularity and 
e) step time. The light blue bars reflect the in-lab values of usual-walking and dual-task walking. The 
results shown here are based on 30-second walking bouts.. 
   
Figure 3:   Scatter plots and Bland Altman plots illustrating the relationship between in-lab dual-task 
step length (a) and gait speed (b) and the daily-living features observed in 30-second walking bouts. 
CV: coefficient of variance; RPC: reproducibility coefficient (1.96*SD). 
(a) 
 
(b) 
 
  
Figure 4:  An example of a) gait speed and b) step regularity for a single subject's 30-second daily-living 
walking bouts and his in-lab usual (green line) and dual-task (red line) values.  
(a) 
 
(b) 
 
 
  
 Table 1: Subject characteristics* 
 (N=150) 
Age (yrs) 76.5±6.3 
Gender (% men) 37.6 
Height [cm] 164±8.83 
Education (yrs) 12.8±3.9 
Body Mass Index (BMI) (kg/m2) 26.2±4.4 
Montreal Cognitive Assessment 24.5±3.6 
SF-36 General Health 61.3±18.5 
Falls Efficacy Scale – International 28.7±8.3 
Mini Best Test of Balance (MINIBEST) 21.9±6.1 
Four Square Step Test (FSST) 12.4±6.8 
Short Physical Performance Battery (SPPB) 9.1±2.3 
Number of falls in the previous 6 months 2 (2,7) 
*Entries are mean±SD, median (percentile 10, percentile 90), or % as indicated.  
 
  
Table 2: Agreement analyses comparing in-lab features of usual and dual-task walking, on the one 
hand, and daily-living features, on the other hand, as measured using the intraclass correlation 
coefficient analyses (two way mixed, absolute, single measure)*.  
In-lab Measures Daily-living Measures 
ICC <0.50 poor reliability 
0.50<ICC<0.75 moderate reliability 
0.75<ICC<0.90 good reliability 
ICC >0.90 excellent reliability 
 
Best 
(Prc90) 
Typical 
(Prc50) 
Worst  
(Prc10) 
Step Length Usual walking 0.657 0.762 0.182 
Dual-task walking 0.520 0.684 0.213 
Gait Speed Usual walking 0.626 0.663 0.137 
Dual-task walking 0.467 0.629 0.147 
Step Regularity Usual walking 0.630 0.561 0.103 
Dual-task walking 0.462 0.602 0.149 
Stride Regularity Usual walking 0.500 0.348 0.023 
Dual-task walking 0.280 0.364 0.046 
Step Time Usual walking 0.267 0.394 0.225 
Dual task walking 0.150 0.255 0.115 
 
  
Table 3: Ranking of in-lab usual walking and in dual-task walking with respect to daily-living 30-
second walking bouts* 
 
 
 
 
 
 
*Entries are mean±SD.   The values indicate that among 50.9% of all daily-living walking bouts, gait 
speed was lower than that seen during in-lab  dual-task walking, for example.  
 
 In-lab usual 
walking 
In-lab dual-task  
walking 
Step length 53.5±23.1 % 45.1±22.9 % 
Gait speed 63.8±23.3 % 50.9±25.4 % 
Step regularity 73.2±26.6 %  64.1±27.5 % 
Stride regularity 72.3±23.7 % 62.1±25.8 % 
Step time 63.8±25.9 % 55.1±29.9 % 
Average 65.3±24.5 % 55.4±26.3 % 
